Loonen AH - Search Results

1

Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome.

Stams WA, Beverloo HB, den Boer ML, de Menezes RX, Stigter RL, van Drunen E, Ramakers-van-Woerden NL, Loonen AH, van Wering ER, Janka-Schaub GE, Pieters R. Stams WA, et al. Among authors: loonen ah. Leukemia. 2006 Mar;20(3):410-6. doi: 10.1038/sj.leu.2404083. Leukemia. 2006. PMID: 16424874

2

Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Among authors: loonen ah. Leuk Res. 1992 Sep;16(9):873-80. doi: 10.1016/0145-2126(92)90033-4. Leuk Res. 1992. PMID: 1405718

3

Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.

Pieters R, Huismans DR, Loonen AH, Peters GJ, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Among authors: loonen ah. Leukemia. 1992 May;6(5):375-80. Leukemia. 1992. PMID: 1593902

4

Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.

Pieters R, Kaspers GJ, van Wering ER, Huismans DR, Loonen AH, Hählen K, Veerman AJ. Pieters R, et al. Among authors: loonen ah. Leukemia. 1993 Mar;7(3):392-7. Leukemia. 1993. PMID: 8445945

5

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hählen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: loonen ah. Blood. 2000 Aug 1;96(3):1094-9. Blood. 2000. PMID: 10910927 Free article.

6

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.

Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R. Ramakers-van Woerden NL, et al. Among authors: loonen ah. Leukemia. 2004 Mar;18(3):521-9. doi: 10.1038/sj.leu.2403253. Leukemia. 2004. PMID: 14712291

7

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

Pieters R, Huismans DR, Loonen AH, Hählen K, van der Does-van den Berg A, van Wering ER, Veerman AJ. Pieters R, et al. Among authors: loonen ah. Lancet. 1991 Aug 17;338(8764):399-403. doi: 10.1016/0140-6736(91)91029-t. Lancet. 1991. PMID: 1678081

8

In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia.

Klumper E, Pieters R, Kaspers GJ, Huismans DR, Loonen AH, Rottier MM, van Wering ER, van der Does-van den Berg A, Hählen K, Creutzig U, et al. Klumper E, et al. Among authors: loonen ah. Leukemia. 1995 Nov;9(11):1864-9. Leukemia. 1995. PMID: 7475276

9

In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.

Ramakers-van Woerden NL, Pieters R, Slater RM, Loonen AH, Beverloo HB, van Drunen E, Heyman M, Moreno TC, Rots MG, van Wering ER, Kamps WA, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: loonen ah. Br J Haematol. 2001 Mar;112(3):680-90. doi: 10.1046/j.1365-2141.2001.02586.x. Br J Haematol. 2001. PMID: 11260073 Free article.

10

In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.

Ramakers-van Woerden NL, Pieters R, Hoelzer D, Slater RM, den Boer ML, Loonen AH, Harbott J, Janka-Schaub GE, Ludwig WD, Ossenkoppele GJ, van Wering ER, Veerman AJ; Dutch and German Leukemia Study Groups. Ramakers-van Woerden NL, et al. Among authors: loonen ah. Med Pediatr Oncol. 2002 Jun;38(6):379-86. doi: 10.1002/mpo.10087. Med Pediatr Oncol. 2002. PMID: 11984797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page